Compare SON & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SON | INDV |
|---|---|---|
| Founded | 1899 | N/A |
| Country | United States | United States |
| Employees | 22000 | N/A |
| Industry | Containers/Packaging | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 4.7B |
| IPO Year | 2014 | 2014 |
| Metric | SON | INDV |
|---|---|---|
| Price | $46.37 | $36.98 |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $60.13 | N/A |
| AVG Volume (30 Days) | 1.6M | ★ 2.0M |
| Earning Date | 04-21-2026 | 06-08-2026 |
| Dividend Yield | ★ 4.39% | N/A |
| EPS Growth | 510.30 | ★ 8100.00 |
| EPS | 0.68 | ★ 0.69 |
| Revenue | ★ $7,518,753,000.00 | $1,239,000,000.00 |
| Revenue This Year | $0.10 | N/A |
| Revenue Next Year | $1.82 | N/A |
| P/E Ratio | $68.21 | ★ $53.49 |
| Revenue Growth | ★ 41.72 | 4.29 |
| 52 Week Low | $38.65 | $11.08 |
| 52 Week High | $58.44 | $41.00 |
| Indicator | SON | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 31.98 | 54.79 |
| Support Level | $44.81 | $34.91 |
| Resistance Level | $46.63 | $37.83 |
| Average True Range (ATR) | 1.26 | 1.57 |
| MACD | -0.38 | -0.35 |
| Stochastic Oscillator | 6.76 | 32.54 |
Sonoco Products Co is engaged in the manufacture and supply of consumer and industrial packaging products, offering paper, metal, and plastic packaging solutions across multiple end markets. The company has two reportable segments: Consumer Packaging and Industrial Paper Packaging. The Consumer Packaging segment provides rigid packaging solutions mainly for food, beverage, household, personal care, and pharmaceutical products, while the Industrial Paper Packaging segment produces paper-based packaging materials such as tubes, cores, and protective packaging, supported by paper mills and recycling operations, serving industrial and consumer markets. It generates the majority of its revenue from the Consumer Packaging segment.
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).